Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (366)	8/24/1999 7:36:00 PM
From: LLCF	Respond to of 1475

HOLY S**T!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! biz.yahoo.com DAK

To: scaram(o)uche who wrote (366)	8/24/1999 9:44:00 PM
From: mike head	Respond to of 1475

Congratulations! You pretty well called it- and that was last year. pax et bonum, mch

To: scaram(o)uche who wrote (366)	8/24/1999 11:04:00 PM
From: LLCF	Read Replies (2) \| Respond to of 1475

So fast track AlloMune is now on the autobahn... if I remeber correctly, this is BTRN's "sweet spot", ie. they have no partner here? You know I was also wondering, how do they "sell" this process... just charge so much per operation and do nothing?? Or package the needed tools and drugs [even though not proprietary to BTRN] and do training? Haven't been around bio enough to have seen an operation patented [totally clueless I'm sure]. Also, could this eventually limit 507 to "other" indications not covered by AlloMune? Sorry to pepper away... just so damn excited... better go get a glass of wine! DAK